Free tool
Dividend paying stocks
We cover 20 companies that currently pay a dividend. The median market value in the group is $5.28B. Across the group, the median move over the past trading day is +0.85%. 95% of the 20 with a 200-day average trade above it. Price change over the past year runs from −25.1% to +81.6% across the middle 80 percent of the group, with a median of +27.9%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
20 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| MRCK34.SA | Merck & Co., Inc. | $388.60B | Mega cap | +81.07% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| AMGN34.SA | Amgen Inc. | $239.09B | Mega cap | +47.79% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | $231.47B | Mega cap | +22.22% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | $89.79M | Micro cap | −23.84% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $67.16M | Micro cap | +1.97% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| EZZ.AX | EZZ Life Science Holdings Limited | $18.76M | Micro cap | −77.25% |
| 7813.T | Platz Co., Ltd. | $17.74M | Micro cap | +18.51% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.